| Literature DB >> 27629532 |
Tetiana Kochubei1, Volodymyr Kitam2, Oksana Maksymchuk1, Oksana Piven1, Lyubov Lukash1.
Abstract
Leukoagglutinin is one of the phytohemagglutinin isolectins isolated from Phaseolus vulgaris. In our recent study, we showed that this lectin is able to influence the growth of human cancer cells in vitro. In addition, using the acridine orange and ethidium bromide staining, we found that leukoagglutinin can induce apoptosis. In order to understand the molecular mechanisms of induction of apoptosis, we performed computational modeling with subsequent experimental verification of theoretical data in vitro. We developed computational models of leukoagglutinin interaction with pro- (FasR and TNFR) and anti-apoptotic (IGF-1 and EGFR) receptors, and confirmed that leukoagglutinin may specifically interact with these receptors. Furthermore, we proved that leukoagglutinin can induce apoptosis in cancer (HEp-2) and non-cancer (4BL) cells, and observed that PHA-L is able to induce apoptosis through the up-regulation of Bax protein and activation of the effector caspase-3 and initiator caspase-8. However, these proteins have no effect on the Bcl-2 expression level.Entities:
Keywords: cancer cells; docking; isolectin; lectin; phytohemagglutinin
Mesh:
Substances:
Year: 2016 PMID: 27629532 DOI: 10.1002/cbin.10683
Source DB: PubMed Journal: Cell Biol Int ISSN: 1065-6995 Impact factor: 3.612